We found that more than 99% of MDA-MB-435s were gated as CD44+ or CD44+/CD24Low (Figure S4 and Figure 6A), indicating that MDA-MB-435s cells are enriched of tumor initiating cells. This evidence concerns the gene CD44 and neoplasm.